Showing 2661-2670 of 8643 results for "".
Marketing Leading Technologies That Support Your Team
https://practicaldermatology.com/issues/august-2025/marketing-leading-technologies-that-support-your-team/36708/From ChatGPT and other artificial intelligence (AI) platforms to the latest mobile apps, technology continues to transform the already dynamic field of health care.Remembering Dr. Robert Sidbury
https://practicaldermatology.com/issues/august-2025/remembering-dr-robert-sidbury/36712/The dermatology community was shaken last month by the sudden passing of Robert Sidbury, MD, MPH, at 61. Dr. Sidbury was Chief of Dermatology at Seattle Children’s Hospital, Professor in the University of Washington Department of Pediatrics, and a former President of the Society for Pediatric DermatScurvy Following Gastric Bypass
https://practicaldermatology.com/issues/august-2025/scurvy-following-gastric-bypass/36701/This report highlights a unique case of scurvy presentation following gastric bypass surgery. A 39-year-old female presented for outpatient dermatology follow-up for a rash that had been present for several months, affecting the buttocks, extremities, and trunk.DWTV Extra: DermLink Scholars Founder Dr. Kelly Frasier
https://practicaldermatology.com/series/dermwire-tv/DWTV-Extra-DermLink-Scholars-Founder-Dr-Kelly-Frasier/36554/DermLink Scholars Founder and CEO Kelly Frasier, DO, MS, CRC, and Alina G. Bridges, DO, FAAD, discuss the organization and its inaugural virtual conference Saturday, August 2. For more information, go to dermlinkscholars.com.DermwireTV: Pharma Partnership Boosts Spesolimab, Plus More
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-pharma-partnership-boosts-spesolimab-plus-more/36519/In this episode of Dermwire TV, two pharma leaders partner to commercialize SPEVIGO for patients with generalized pustular psoriasis; interest in red light devices is up; and experts take a look at what’s new in psoriasis treatments on the Practical Dermatology Podcast.Evaluating Lebrikizumab in Pigmented Skin
https://practicaldermatology.com/series/updates-atopic-dermatitis/evaluating-lebrikizumab-in-pigmented-skin/36490/Andrew Alexis, MD, MPH, discusses new data presented at the Revolutionizing Atopic Dermatitis (RAD) Conference from the phase 3b Admirable trial, the first dedicated study for evaluating the efficacy and safety of Lilly's FDA-approved medicine in adult and adolescent patients with pigmented skin andAI for Patient Education and More
https://practicaldermatology.com/series/c-suite-chats/ai-for-patient-education-and-more/36239/Anastasia Georgievskaya, founder of Haut.AI, discusses the impact of new artificial intelligence tools such as a virtual skincare try-on that shows customers how sunscreen and its ingredients will impact skin over time.Nemluvio Shows Efficacy in AD
https://practicaldermatology.com/series/dermwire-tv/nemluvio-shows-efficacy-in-ad/36134/In this episode of DermwireTV, Nemluvio (nemolizumab) showed efficacy in atopic dermatitis in recent studies; strontium cream helps manage pruritus in hidradenitis suppurativa (HS); and Lisa Swanson and Peter Lio get viewers up to date on dupilumab’s effectiveness at halting atopic march.FDA Grants Interchangeability to HADLIMA
https://practicaldermatology.com/series/dermwire-tv/fda-grants-interchangeability-to-hadlima/35962/In this week's DermwireTV, the FDA grants full interchangeability to HADLIMA; new research shows the impact of UV exposure on global skin cancer cases; and coverage from Music City SCALE addresses barriers to patient access to new therapies.Fractional Lasers for NMSC and More
https://practicaldermatology.com/conferences/scale-2025/fractional-lasers-for-nmsc-and-more/35876/Joel L. Cohen, MD, FAAD, and Matthew M. Avram, MD, talk about research involving fractional lasers, including as part of combination treatments for nonmelanoma skin cancer, at Music City SCALE 2025.